Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Lara-Mejía

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Letter in ResponseOscar Arrieta, Luis Lara-Mejía
The Lancet. Oncology|September 5, 2020
Carboplatin plus etoposide or topotecan for small-cell lung cancerOscar Arrieta, Luis Lara-Mejía, Zyanya Lucia Zatarain-Barrón
Oncology (Williston Park, N.Y.)|July 10, 2020
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung CancerLuis Lara-Mejía, Roberto Sánchez-Reyes, Alejandro Avilés-Salas, et al.
Oncotarget|July 3, 2023
Obesity paradox and lung cancer, metformin-based therapeutic opportunity?Pedro Barrios-Bernal, Norma Hernández-Pedro, Luis Lara-Mejía, et al.
Oncology Research and Treatment|September 18, 2024
EGFR plus MET Targeted Therapies for Overcoming Treatment Resistance in EGFR-Mutant Non-Small Cell Lung Cancer: A Case ReportMaria F Martínez-Hernandez, Luis Lara-Mejía, Carlos Izquierdo-Tolosa, et al.
Frontiers in Oncology|April 10, 2023
Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancerPamela Soberanis Pina, Luis Lara-Mejía, Venecia Matias-Cruz, et al.
Palliative & Supportive Care|October 10, 2022
Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancerAna Gonzalez-Ling, Oscar Galindo Vázquez, Marcos Espinoza Bello, et al.
Thoracic Cancer|October 8, 2020
Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesotheliomaOscar Arrieta, Francisco Lozano-Ruiz, Monika Blake-Cerda, et al.
Cancer Biomarkers : Section a of Disease Markers|December 18, 2023
Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKIDavid Heredia, Laura Bolaño-Guerra, Angel Valencia-Velarde, et al.
BMC Cancer|September 3, 2020
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutationsOscar Arrieta, Rodrigo Catalán, Silvia Guzmán-Vazquez, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Letter in ResponseOscar Arrieta, Luis Lara-Mejía
The Lancet. Oncology|September 5, 2020
Carboplatin plus etoposide or topotecan for small-cell lung cancerOscar Arrieta, Luis Lara-Mejía, Zyanya Lucia Zatarain-Barrón
Oncology (Williston Park, N.Y.)|July 10, 2020
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung CancerLuis Lara-Mejía, Roberto Sánchez-Reyes, Alejandro Avilés-Salas, et al.
Oncotarget|July 3, 2023
Obesity paradox and lung cancer, metformin-based therapeutic opportunity?Pedro Barrios-Bernal, Norma Hernández-Pedro, Luis Lara-Mejía, et al.
Oncology Research and Treatment|September 18, 2024
EGFR plus MET Targeted Therapies for Overcoming Treatment Resistance in EGFR-Mutant Non-Small Cell Lung Cancer: A Case ReportMaria F Martínez-Hernandez, Luis Lara-Mejía, Carlos Izquierdo-Tolosa, et al.
Frontiers in Oncology|April 10, 2023
Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancerPamela Soberanis Pina, Luis Lara-Mejía, Venecia Matias-Cruz, et al.
Palliative & Supportive Care|October 10, 2022
Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancerAna Gonzalez-Ling, Oscar Galindo Vázquez, Marcos Espinoza Bello, et al.
Thoracic Cancer|October 8, 2020
Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesotheliomaOscar Arrieta, Francisco Lozano-Ruiz, Monika Blake-Cerda, et al.
Cancer Biomarkers : Section a of Disease Markers|December 18, 2023
Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKIDavid Heredia, Laura Bolaño-Guerra, Angel Valencia-Velarde, et al.
BMC Cancer|September 3, 2020
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutationsOscar Arrieta, Rodrigo Catalán, Silvia Guzmán-Vazquez, et al.
Pageof 4